Actinium Pharma on Twitter: "Actinium's Pivotal Phase 3 SIERRA trial fully enrolled. Data update in 4Q 2021 with topline data expected in mid-2022. Iomab-B showing clear value proposition through 75% enrollment. Learn
Systweak Announces 7 Days Fully Functional Trial Version of Systweak VPN - Windows Users
Suspects in Dutch trial 'fully responsible' for MH17 downing, prosecution says | Reuters
Digital silver lining seen in failed COVID-19 drug trial | Newsroom